Search Results

You searched for : Merck  

India’s first indigenously developed vaccine against cervical cancer will hit the market soon

India’s first indigenously developed human papillomavirus (HPV) vaccine will be soon administered to women in near future. The research and development related to vaccines ...
Sep 02

Biomarker startup Koneksa gains $45 million

Digital biomarker startup Koneksa has raised $45 million in their Series C funding round....
Feb 08

BioMed X Institute and Merck KGaA, Darmstadt, Germany, extend collaboration in Oncology

Corporate News Updates; Pharma Feb 3rd 2022...
Feb 03

HexaHealth and India’s in-patient care segment

Out of the $130 billion spent on healthcare, 60% is spent on in-patient care across private providers alone. Despite its importance and size, the ...
Jan 19

Transcarent raises $200M in Series C funding

California-based healthcare company, Transcarent, raised $200 million in their Series C fund round by Kinnevik and Human Capital. ...
Jan 12

ANI Pharmaceuticals announces FDA approval of purified Cortrophin Gel

...
Nov 03

Evaxion Biotech announces Clinical Collaboration to evaluate Keytruda in melanoma patients

Latest news updates...
Oct 26

Merck launches the cosmetic active ingredient RonaCare to strengthen the skin's resilience

Latest pharma updates...
Oct 12

Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106

Latest Pharma Update...
Aug 23

Merck Announces U.S. FDA Approval of VAXNEUVANCE for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older

Pneumococcal disease is an infection caused by bacteria called Streptococcus pneumoniae, or pneumococcus....
Jul 17

BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in Oncology

Pharma News Update July 8...
Jul 09

Alzheimer's Disease Fast Facts

Facts about the Alzheimer's disease...
Jul 08

LYNPARZA (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

Only PARP Inhibitor to Demonstrate Overall Survival Versus New Hormonal Treatments in BRCA1/2-Mutated Advanced Prostate Cancer...
Jun 24

Merck to Participate in the Guggenheim Biopharma Strategy Series

Merck Research Laboratories, is scheduled to participate in a virtual fireside chat at the Guggenheim Biopharma Strategy Series...
Jun 19

Merck Announces Supply Agreement with U.S. Government for Molnupiravir

...
Jun 09

Merck Announces Positive Topline Results from PNEU-DIRECTION (V114-027) and PNEU-PLAN (V114-024)

Phase 3 Pediatric Studies for V114, Merck’s Investigational...
May 22

M2GEN announces new collaboration with Merck to advance Cancer therapies

Another pharma collaboration for the advancement of cancer therapies ...
Mar 22

Debiopharm grants exclusive license to Merck for Xevinapant

This worldwide exclusive license to Merck KGaA, Darmstadt, Germany for the development and commercialization of Xevinapant ...
Mar 03

Lupin Launches Posaconazole Delayed-Release Tablets

Lupin & its AET Pharma US Inc. (part of Tiefenbacher Group) received an approval for its ANDA from the USFDA...
Feb 17

Philips and Merck partner to advance personalized fertility treatment

Royal Philips, a global leader in health technology, today announced a multi-year partnership with Merck, a leading science and technology company, to develop clinical-...
Jan 15

U.S. FDA Accepts for Priority Review the Biologics License Application for V114

Merck announced the U.S. FDA accepted for priority review a Biologics License Application for V114, Merck’s investigational 15-valent pneumococcal conjugate vaccine, for ...
Jan 12

Propanc Biopharma Advances POP1 Joint Research and Drug Discovery Program

The drugs discovery program is for servicing the US$111.2B global Metastatic Cancer market...
Dec 31

LYNPARZA (olaparib) Receives Three New Approvals in Japan

LYNPARZA has been approved in Japan for the treatment of three types of advanced cancer: ovarian, prostate and pancreatic cancer....
Dec 28

A2 Biotherapeutics enters into collaboration agreement With Merck ; cell therapy for solid tumor Cancers

...
Dec 26

Merck Announces Supply Agreement with U.S. Government for Initial Doses of Investigational Biological Therapy for the Treatment of COVID-19

...
Dec 23

25 Matching result(s) found!

-Advertisements-




Trending Now

Sexual wellness superstore, Love Depot launches digital campaign to deliver every desireMarch 28, 2024
Recharge Your Life: Simple Ways to Boost Your Physical and Mental EnergyMarch 28, 2024
The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024
Surmandal's Tribute to the Legends of Hindustani Classical MusicMarch 26, 2024
In Moscow, over 350,000 mammograms have been analyzed using artificial intelligence as part of the compulsory health insurance programMarch 26, 2024
Embark on a Creative Journey: "Kala For A Cause" Unveils Pottery Workshop Series March 26, 2024
Healthtech pioneer Aurora Innovation appoints new CEO – expands in Europe with service that streamlines patient-healthcare interactionMarch 26, 2024
In A Rare Feat, 45 YO Woman Walks Within 6 Hrs. Of Dual Robotic Surgery In A Single Operation At HCGMCCMarch 26, 2024
Improve Cancer Care through Automated CT Analysis: Oncoshield – CTMarch 26, 2024